Liothyronine Tablet Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 5 mcg, 25 mcg, 50 mcg
Reference Brands: Cytomel®(US); Tertroxin®(EU)
Category:
Women's Health
Liothyronine Sodium is a fast-acting T3 thyroid hormone used to treat hypothyroidism and related disorders. Available in 5–100 mcg oral tablets, it’s sold under top brands like Cytomel® (US) and Tertroxin® (EU). Widely used when levothyroxine is inadequate, liothyronine supports vital thyroid therapy needs across clinics and hospitals in the US and EU.
Liothyronine Tablet is available in Oral tablets
and strengths such as 5 mcg, 25 mcg, 50 mcg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Liothyronine Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Liothyronine Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Liothyronine Sodium is a synthetic form of the T3 thyroid hormone used to treat hypothyroidism, goiter, and thyroid hormone resistance. Available in oral tablet form, common strengths include 5 mcg, 20 mcg, 25 mcg, 50 mcg, and 100 mcg, marketed under brands like Cytomel® (Pfizer, US) and Tertroxin® (Amdipharm, EU). It ensures rapid onset of action and is often used when levothyroxine alone is insufficient. Liothyronine is in high demand across clinical endocrinology practices and hospital supply chains, making it a valuable product for pharmaceutical wholesalers and B2B distributors in the US and EU markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing